Research ArticleArticle
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review
Aki Shiozawa, Shelagh M. Szabo, Anna Bolzani, Antoinette Cheung and Hyon K. Choi
The Journal of Rheumatology February 2017, jrheum.160452; DOI: https://doi.org/10.3899/jrheum.160452
Aki Shiozawa
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Shelagh M. Szabo
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Anna Bolzani
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Antoinette Cheung
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Hyon K. Choi
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review
Aki Shiozawa, Shelagh M. Szabo, Anna Bolzani, Antoinette Cheung, Hyon K. Choi
The Journal of Rheumatology Feb 2017, jrheum.160452; DOI: 10.3899/jrheum.160452